CDMO Or No CDMO... That Is The Question

In biomanufacturing, speed to market can make or break a product’s success. While the “fail fast” mindset works in many industries, pharmaceutical development is far too costly for missteps. Instead, companies must focus on succeeding quickly by assessing internal capabilities and identifying gaps early. For some, in-house resources may suffice; for others, outsourcing to the right partner can accelerate timelines and reduce risk. The key lies in knowing when external expertise is necessary and making informed decisions that align with strategic goals. By evaluating organizational strengths and weaknesses upfront, businesses can mitigate delays, avoid regulatory pitfalls, and stay competitive in a fast-moving market.

Explore how to determine the right path for your biomanufacturing strategy.